LeonaBio (LONA) Short-term Investments (2020 - 2026)

LeonaBio (LONA) has 7 years of Short-term Investments data on file, last reported at $34.8 million in Q1 2026.

• Quarterly Short-term Investments rose 240.03% year-over-year to $34.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $34.8 million (up 240.03% YoY) and the FY2025 annual result came in at $19.1 million, up 571.66% from the prior year.
• Short-term Investments grew to $34.8 million in Q1 2026 per LONA's latest filing, from $19.1 million in the prior quarter.
• Across five years, Short-term Investments topped out at $157.3 million in Q2 2022 and bottomed at $2.8 million in Q4 2024.
• The 5-year median for Short-term Investments is $44.3 million (2024), against an average of $56.3 million.
• The widest annual swing landed in 2024, when Short-term Investments sank 95.01%; it then surged 571.66% in 2025.
• Tracing LONA's Short-term Investments over 5 years: stood at $104.4 million in 2022, then slumped by 45.55% to $56.8 million in 2023, then slumped by 95.01% to $2.8 million in 2024, then surged by 571.66% to $19.1 million in 2025, then soared by 82.87% to $34.8 million in 2026.
• Per Business Quant, the three latest LONA Short-term Investments figures stand at $34.8 million (Q1 2026), $19.1 million (Q4 2025), and $4.4 million (Q3 2025).

Peer Comparison